Client Result

Oncology Diagnostics Landscape Assessment and Model

Project Overview

DeciBio performed a global voice-of-customer (VOC) research campaign with oncologists and pathologists to understand the current adoption and expected trends for NGS kits in oncology diagnostics in the U.S., EU, and APAC.

DeciBio Approach

Primary Research

  • Conducted 32 in-depth interviews with oncologists, pathologists, and lab directors to better understand current and future use, as well as trends for NGS tissue testing and liquid biopsy
  • Interviews spanned the U.S., EU, and APAC and across various institution types such as reference labs / CROs, community hospitals, and academic medical centers

Quantitative Analyses

Developed a comprehensive model of the current and future (5-year forecast) oncology diagnostics market, including segmentation by:

  • Geography: U.S., Europe, APAC
  • Cancer type: Lung cancer, breast cancer, colorectal cancer, others
  • Sample type: Tissue, liquid
  • Application: Therapy selection, MRD (solid tumors), surveillance / monitoring
  • Setting: Academic hospital lab, community hospital lab, commercial reference lab
At a glance
32
Interviews
11
Countries Covered
>30
Model segmentations
Outcomes

DeciBio delivered a summary report and detailed model outlining:

  • Current use of genomic biomarker assays across regions
  • NGS use and liquid biopsy use in routine clinical care
  • Trends and factors affecting centralization of genomic testing, as well as panel size preferences
  • Trends and factors in regulatory implementation / compliance and IVD use
  • Country-specific reimbursement models and drivers and moderators of oncology NGS testing
Timeline

8 weeks

Geographic Scope

U.S., EU, APAC

Industry

Clinical Diagnostics

capabilities

Voice-Of-Customer Research

Biomarker and Diagnostic Strategy

Addressable Market Sizing

Related Client Results
Clinical Diagnostics
Genetic Testing Lab Target Assessment
A large pharmaceutical company asked DeciBio to help it identify and evaluate clinical genetic testing labs for potential partnership or acquisition
Target Identification
Clinical Diagnostics
MRD Monitoring Market Assessment and Strategy
A diagnostics player wanted to determine which indications and use cases to target and develop a product road map for its planned MRD offering
Biomarker and Diagnostic Strategy
Go-to-Market Strategy
Clinical Diagnostics
Early Cancer Detection Competitor Landscape Monitoring
A top diagnostics player wanted to monitor the commercial, clinical, research, and corporate activities in the public domain for three of the key players in the cancer early detection market.
Competitive Analysis
Clinical Diagnostics
IVDR Diagnostics Strategy
A top-10 diagnostics company wanted to gauge laboratory preparedness and reactions to the impending implementation of IVDR, and how that would impact portfolio strategy
Voice-Of-Customer Research
Biomarker and Diagnostic Strategy

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Precision Medicine. Precision Insights.
© DeciBio 2022. All rights reserved.
Privacy | Terms & Conditions